首页 | 本学科首页   官方微博 | 高级检索  
     

蛋白酪氨酸磷酸酶-1B与2型糖尿病
引用本文:王淼,邹大进. 蛋白酪氨酸磷酸酶-1B与2型糖尿病[J]. 国际内分泌代谢杂志, 2006, 26(6): 388-390
作者姓名:王淼  邹大进
作者单位:200433,上海,第二军医大学长海医院内分泌科
摘    要:研究证实,蛋白酪氨酸磷酸酶-1B(PTP-1B)主要通过以下几方面参与2型糖尿病的发病(1)可与胰岛素受体及其底物相作用,减弱胰岛素信号转导,引起胰岛素抵抗。(2)参与对胰岛β细胞数量的调节。(3)与瘦素抵抗及脂代谢异常关系密切,由此引发并加重2型糖尿病。目前已合成各种类型的PTP-1B抑制剂,有良好的降糖等疗效,临床应用前景广阔。

关 键 词:蛋白酪氨酸磷酸酶-1B  2型糖尿病  胰岛素抵抗  蛋白酪氨酸磷酸酶-1B抑制剂
收稿时间:2005-12-10
修稿时间:2005-12-10

Protein tyrosine phosphatase 1B and type 2 diabetes
WANG Miao,ZOU Da-jin. Protein tyrosine phosphatase 1B and type 2 diabetes[J]. International JOurnal of Endocrinology and Metabolism, 2006, 26(6): 388-390
Authors:WANG Miao  ZOU Da-jin
Affiliation:Department of Endocrinology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China
Abstract:Protein tyrosine phosphatase 1B(PTP-1B) is proved to contribute to the pathogenesis of type 2 diabetes through the following ways:(1)PTP-1B is associated with insulin receptor and down regulates insulin signaling which causes insulin resistance. (2) PTP-1B participates in the regulation of pancreas beta cells mass. (3) PTP-1B may play a role in leptin resistance and lipid metabolism disorder. All of this promote the pathogenesis and development of type 2 diabetes. Several kinds of PTP-1B inhibitors have been synthetized which can normalize hyperglycaemia, and have spacious prospect of clinical application.
Keywords:Protein tyrosine phosphatase 1B  Type 2 diabetes  Insulin resistance  Protein tyrosine phosphatase 1B inhibitor
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号